SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-107061
Filing Date
2020-09-21
Accepted
2020-09-21 17:26:07
Documents
13
Period of Report
2020-09-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2031018-4_8k.htm   iXBRL 8-K 49243
2 EXHIBIT 1.1 tm2031018d4_ex1-1.htm EX-1.1 243528
3 EXHIBIT 5.1 tm2031018d4_ex5-1.htm EX-5.1 16963
4 GRAPHIC tm2031018d4_ex5-1img001.jpg GRAPHIC 9598
  Complete submission text file 0001104659-20-107061.txt   566181

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ckpt-20200917.xsd EX-101.SCH 3198
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ckpt-20200917_lab.xml EX-101.LAB 34591
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ckpt-20200917_pre.xml EX-101.PRE 22718
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2031018-4_8k_htm.xml XML 3726
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38128 | Film No.: 201187251
SIC: 2834 Pharmaceutical Preparations